Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) >=3y on nivolumab (NIVO) +- ipilimumab (IPI) or IPI in CheckMate 067.
Nivolumab;Ipilimumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) >=3y on nivolumab (NIVO) +- ipilimumab (IPI) or IPI in CheckMate 067. ### Output: Nivolumab;Ipilimumab